LB Pharmaceuticals Inc (LBRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
LB Pharmaceuticals Inc (LBRX)
Company Research
Source: Seeking Alpha
Company Participants Heather Turner - CEO & Director Conference Call Participants Ami Fadia - Needham & Company, LLC, Research Division Presentation Ami Fadia Needham & Company, LLC, Research Division Good morning, everyone. I'm Ami Fadia, biotech analyst here at Needham. Welcome to the next session with LB Pharmaceuticals. It's my pleasure to be hosting Heather Turner, CEO of the company. Heather, thank you so much for participating in our conference and taking the time for this session. I will turn it over to you for the presentation, and we'll have some time at the end for Q&A. And maybe this is a good time to remind our listeners that they can send me any questions that they'd like me to ask through the dashboard. With that, over to you, Heather. Heather Turner CEO & Director Thank you, Ami, for including us in this conference today. We're really happy to be here in the Zoomaverse with you all. I will be making forward-looking statements today. The visio
Show less
Read more
Impact Snapshot
Event Time:
LBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LBRX alerts
High impacting LB Pharmaceuticals Inc news events
Weekly update
A roundup of the hottest topics
LBRX
News
- LB Pharmaceuticals Highlights LB-102 Phase 3 Schizophrenia Path, Funding Runway to 2029 at Needham [Yahoo! Finance]Yahoo! Finance
- LB Pharmaceuticals (LBRX) is now covered by Craig Hallum. They set a "buy" rating and a $36.00 price target on the stock.MarketBeat
- LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)GlobeNewswire
LBRX
Earnings
- 3/26/26 - In-Line
LBRX
Sec Filings
- 4/15/26 - Form EFFECT
- 4/14/26 - Form 424B3
- 4/6/26 - Form S-1
- LBRX's page on the SEC website